Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ASTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 9.10%
March 31, 2026 9.35%
December 31, 2025 8.27%
September 30, 2025 8.53%
June 30, 2025 10.85%
March 31, 2025 10.39%
December 31, 2024 6.37%
September 30, 2024 13.83%
June 30, 2024 13.58%
March 31, 2024 17.03%
December 31, 2023 9.65%
September 30, 2023 19.67%
June 30, 2023 14.67%
March 31, 2023 12.92%
December 31, 2022 12.58%
September 30, 2022 22.55%
June 30, 2022 13.08%
March 31, 2022 14.49%
December 31, 2021 9.66%
September 30, 2021 33.01%
June 30, 2021 20.03%
March 31, 2021 17.75%
December 31, 2020 19.99%
September 30, 2020 29.77%
June 30, 2020 14.81%
Date Value
March 31, 2020 9.81%
December 31, 2019 12.52%
September 30, 2019 12.82%
June 30, 2019 18.63%
March 31, 2019 8.26%
December 31, 2018 20.45%
September 30, 2018 39.22%
June 30, 2018 15.14%
March 31, 2018 27.74%
December 31, 2017 23.27%
September 30, 2017 -0.40%
June 30, 2017 2.84%
March 31, 2017 5.97%
March 31, 2016 17.31%
December 31, 2015 19.24%
September 30, 2015 26.63%
June 30, 2015 25.21%
March 31, 2015 31.62%
December 31, 2014 17.77%
September 30, 2014 45.52%
June 30, 2014 20.09%
January 31, 2014 4.19%
October 31, 2013 17.58%
July 31, 2013 8.50%
April 30, 2013 23.68%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Starling Oncology, Inc. 15.70%
Agilon Health, Inc. 6.71%
Nakamoto, Inc. 24.31%
American Oncology Network, Inc. --
Nutex Health, Inc. 67.04%